Johnson & Johnson delivered stronger-than-expected Q1 earnings that prompted the healthcare giant to boost its full-year guidance.<\/p>\n\n\n\n
JNJ reported a Q1 EPS of $2.68 on revenue of $24.7 billion to top the average analyst estimate for EPS of $2.50 on revenue of $23.61B. Sales rose 5.6% year-over-year with pharma revenue generating $13.41B – up 4.2% YoY.<\/p>\n\n\n\n
\u201cOur first quarter results demonstrate strong performance across all three segments of our business and reflect the dedication of Johnson & Johnson colleagues around the world,\u201d said Joaquin Duato, chairman of the Board and chief executive officer.<\/p>\n\n\n\n
Following a better-than-expected quarter, JNJ boosted its full-year forecast so it now expects EPS between $10.60 and $10.70, up from the prior range of $10.45-$10.65. Revenue is seen between $97.9B and $98.9B, an upgrade relative to the prior range of $96.9B-$97.9B.<\/p>\n\n\n\n
\u201cWith this momentum, I look forward to the remainder of the year, one filled with exciting catalysts that will create both near- and long-term value for patients and all of our stakeholders,\u201d Duato added.<\/p>\n","protected":false},"excerpt":{"rendered":"
Johnson & Johnson delivered stronger-than-expected Q1 earnings that prompted the healthcare giant to boost its full-year guidance. JNJ reported a Q1 EPS of $2.68 on revenue of $24.7 billion to top the average analyst estimate for EPS of $2.50 on revenue of $23.61B. Sales rose 5.6% year-over-year with pharma revenue generating $13.41B – up 4.2% …<\/p>\n","protected":false},"author":9,"featured_media":44351,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39,36],"tags":[7113,7825],"class_list":["post-83004","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-global-stock-markets","category-market-updates","tag-earnings","tag-johnson-johnson"],"_links":{"self":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/83004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/comments?post=83004"}],"version-history":[{"count":1,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/83004\/revisions"}],"predecessor-version":[{"id":83005,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/83004\/revisions\/83005"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media\/44351"}],"wp:attachment":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media?parent=83004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/categories?post=83004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/tags?post=83004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}